NDC 60429-503

NDC 60429-503

NDC 60429-503 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 60429-503
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 60429-503-05 [60429050305]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-45 [60429050345]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-30 [60429050330]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-15 [60429050315]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-18 [60429050318]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-90 [60429050390]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-01 [60429050301]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-60 [60429050360]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-10 [60429050310]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

NDC 60429-503-12 [60429050312]

Alprazolam TABLET
Marketing CategoryANDA
Application NumberANDA074174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-03-28
Marketing End Date2017-10-10

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.